Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Engineering of Anti-CD133 Trispecific Molecule Capable of Inducing NK Expansion and Driving Antibody-Dependent Cell-Mediated Cytotoxicity.
Cancer Res Treat. 2017 Oct;49(4):1140-1152. doi: 10.4143/crt.2016.491. Epub 2017 Feb 20.
Cancer Res Treat. 2017.
PMID: 28231426
Free PMC article.
IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function.
Vallera DA, Felices M, McElmurry R, McCullar V, Zhou X, Schmohl JU, Zhang B, Lenvik AJ, Panoskaltsis-Mortari A, Verneris MR, Tolar J, Cooley S, Weisdorf DJ, Blazar BR, Miller JS.
Vallera DA, et al. Among authors: lenvik aj.
Clin Cancer Res. 2016 Jul 15;22(14):3440-50. doi: 10.1158/1078-0432.CCR-15-2710. Epub 2016 Feb 4.
Clin Cancer Res. 2016.
PMID: 26847056
Free PMC article.
Item in Clipboard
Potent Cytolytic Activity and Specific IL15 Delivery in a Second-Generation Trispecific Killer Engager.
Felices M, Lenvik TR, Kodal B, Lenvik AJ, Hinderlie P, Bendzick LE, Schirm DK, Kaminski MF, McElmurry RT, Geller MA, Eckfeldt CE, Vallera DA, Miller JS.
Felices M, et al. Among authors: lenvik aj.
Cancer Immunol Res. 2020 Sep;8(9):1139-1149. doi: 10.1158/2326-6066.CIR-19-0837. Epub 2020 Jul 13.
Cancer Immunol Res. 2020.
PMID: 32661096
Free PMC article.
Item in Clipboard
IL-15 super-agonist (ALT-803) enhances natural killer (NK) cell function against ovarian cancer.
Felices M, Chu S, Kodal B, Bendzick L, Ryan C, Lenvik AJ, Boylan KLM, Wong HC, Skubitz APN, Miller JS, Geller MA.
Felices M, et al. Among authors: lenvik aj.
Gynecol Oncol. 2017 Jun;145(3):453-461. doi: 10.1016/j.ygyno.2017.02.028. Epub 2017 Feb 22.
Gynecol Oncol. 2017.
PMID: 28236454
Free PMC article.
Item in Clipboard
Continuous treatment with IL-15 exhausts human NK cells via a metabolic defect.
Felices M, Lenvik AJ, McElmurry R, Chu S, Hinderlie P, Bendzick L, Geller MA, Tolar J, Blazar BR, Miller JS.
Felices M, et al. Among authors: lenvik aj.
JCI Insight. 2018 Feb 8;3(3):e96219. doi: 10.1172/jci.insight.96219. eCollection 2018 Feb 8.
JCI Insight. 2018.
PMID: 29415897
Free PMC article.
Item in Clipboard
CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets.
Gleason MK, Ross JA, Warlick ED, Lund TC, Verneris MR, Wiernik A, Spellman S, Haagenson MD, Lenvik AJ, Litzow MR, Epling-Burnette PK, Blazar BR, Weiner LM, Weisdorf DJ, Vallera DA, Miller JS.
Gleason MK, et al. Among authors: lenvik aj.
Blood. 2014 May 8;123(19):3016-26. doi: 10.1182/blood-2013-10-533398. Epub 2014 Mar 20.
Blood. 2014.
PMID: 24652987
Free PMC article.
Item in Clipboard
Cite
Cite